Company / Operating Cash Flow per Share
Coherus Oncology, Inc. Operating Cash Flow per Share History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.42
FY2019
5-year range
-$4.37 / $0.46
FY2015-FY2019
Trend
+115.6%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-4.37 to $0.42 over the past 2 years.
Based on SEC 10-K filings.
0.42 in FY2019.
Improved from $-4.37 to $0.42 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, operating cash flow per share increased 115.6% year-over-year.
- Peak operating cash flow per share was recorded in FY2015.
- Lowest operating cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $0.42 | +115.6% |
| FY2018 | -$2.66 | +39.1% |
| FY2017 | -$4.37 | -612.8% |
| FY2016 | -$0.61 | -232.3% |
| FY2015 | $0.46 | +112.3% |
| FY2014 | -$3.77 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026